$RNA News BlackBerry plunges as it slashes jobs,
Post# of 72711
Posted On: 01/07/2014 2:29:15 PM
$RNA News
BlackBerry plunges as it slashes jobs, forecasts 3:58 p.m. Sept. 20, 2013 - Saumya Vaishampayan
Prosensa notably higher on the day 2:26 p.m. Jan. 6, 2014 - Seeking Alpha
This FDA Letter About Sarepta and Accelerated Approval for Eteplirsen Will Blow Your Mind 12:37 p.m. Jan. 6, 2014 - TheStreet.com
The 4 Worst IPOs of 2013 12:00 a.m. Dec. 12, 2013 - InvestorPlace.com
Prosensa Holding NV's CEO Discusses Q3 2013 Results - Earnings Call Transcript 5:14 p.m. Nov. 18, 2013 - Seeking Alpha
Sarepta Therapeutics: No Longer A Momentum Play, But Long-Term Value Remains 3:30 a.m. Nov. 14, 2013 - Seeking Alpha
Glaxo's Heart Candidate Disappoints - Analyst Blog 5:20 p.m. Nov. 13, 2013 - Zacks.com
FDA Wants More Testing of Muscular-Dystrophy Drug 4:23 p.m. Nov. 12, 2013 - WSJ.com
Health-Care Stocks: Where to Find Value 6:08 a.m. Nov. 12, 2013 - Barrons.com
Sarepta Therapeutics: Underappreciated Clinical And Regulatory Risk Following Analysis Of Prosensa Failure 10:12 a.m. Oct. 30, 2013 - Seeking Alpha
Sarepta On The Move 2:44 p.m. Oct. 21, 2013 - Seeking Alpha
Insiders Are Buying Fate Therapeutics 10:20 a.m. Oct. 9, 2013 - GuruFocus.com
Sarepta Shares Continue to Inch Up - Analyst Blog 3:45 p.m. Sept. 30, 2013 - Zacks.com
Sarepta Takes The Lead In Muscular Dystrophy Race 3:25 p.m. Sept. 30, 2013 - Investors Business Daily
Is It Time To Go Long Sarepta Therapeutics? 1:34 p.m. Sept. 26, 2013 - Seeking Alpha
UPDATE: J.P. Morgan Downgrades Prosensa Following Drisapersen DEMAND-III Study Failure 7:31 a.m. Sept. 24, 2013 - benzinga.com
Prosensa Done In by Data 5:24 a.m. Sept. 24, 2013 - Barrons.com
Sarepta Therapeutics: A Bigger Cake Outweighs A Lower Chance For A Party 2:47 p.m. Sept. 23, 2013 - Seeking Alpha
Prosensa Collapses on Drug Trial Failure - Analyst Blog 12:00 p.m. Sept. 23, 2013 - Zacks.com
UPDATE: Wedbush Downgrades Prosensa Following Bad News About Drisapersen 9:34 a.m. Sept. 23, 2013 - benzinga.com
Phase III Trial Ruins Prosensa's Drisapersen, Sarepta Rallies Strongly 8:30 a.m. Sept. 23, 2013 - Seeking Alpha
Prosensa to Present Corporate Overview at the 32nd Annual J.P. Morgan Healthcare Conference 8:00 a.m. Today - GlobeNewswire
Prosensa Comments on Drisapersen Program Update 11:07 a.m. Dec. 19, 2013 - GlobeNewswire
Prosensa Announces Extraordinary Shareholders Meeting to Appoint Dr. Georges Gemayel 9:15 a.m. Dec. 10, 2013 - GlobeNewswire
Prosensa and Partners Awarded Second European Consortium FP7 Research Grant 8:00 a.m. Nov. 25, 2013 - GlobeNewswire
Prosensa Announces Third Quarter 2013 Financial Results and Recent Corporate Developments 8:01 a.m. Nov. 18, 2013 - GlobeNewswire
Prosensa Awarded Best Biotech Pipeline 2013 at the Rare & Orphan Advocacy and Research (ROAR) Awards 8:00 a.m. Nov. 15, 2013 - GlobeNewswire
Prosensa Holding N.V. to Webcast Conference Call Discussing 3rd Quarter 2013 Financial Results on November 18, 2013 8:10 a.m. Nov. 11, 2013 - GlobeNewswire
Prosensa Enrolls 100th Patient to its Natural History Study of Duchenne Muscular Dystrophy 8:01 a.m. Nov. 7, 2013 - GlobeNewswire
Prosensa to Host Conference Call to Discuss Recent Drisapersen Data Presentations 3:31 p.m. Oct. 3, 2013 - GlobeNewswire
Law Offices of Todd M. Garber Announces Investigation of Prosensa Holding B.V. 3:02 p.m. Sept. 30, 2013 - BusinessWire
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Prosensa Holding N.V. 7:30 a.m. Sept. 30, 2013 - PR Newswire
The Rosen Law Firm Announces Investigation of Shareholder Securities Claims Against Prosensa Holding NV - RNA 10:02 p.m. Sept. 27, 2013 - BusinessWire
Glancy Binkow & Goldberg LLP Encourages Investors of Prosensa Holding B.V. With Losses of $100,000 or More to Contact the Firm 8:32 p.m. Sept. 24, 2013 - BusinessWire
Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of Prosensa Holding B.V. 3:16 p.m. Sept. 24, 2013 - BusinessWire
Prosensa to Present at Upcoming Investor Conferences 12:32 p.m. Sept. 24, 2013 - GlobeNewswire
Five Star Equities Issues New Research Reports on CYCC, RNA, RVP and SRPT 7:41 a.m. Sept. 23, 2013 - ACCESSWIRE
GSK and Prosensa Announce Primary Endpoint Not Met in Phase III Study of Drisapersen in Patients With Duchenne Muscular Dystrophy 6:00 a.m. Sept. 20, 2013 - GlobeNewswire
Prosensa Initiates First Patient Dosing in Phase I/II trial of PRO053 7:30 a.m. Sept. 6, 2013 - GlobeNewswire
Prosensa Announces Second Quarter 2013 Financial Results and Recent Corporate Developments 6:00 a.m. Aug. 28, 2013 - GlobeNewswire
Prosensa Holding N.V. to Webcast Conference Call Discussing Second Quarter 2013 Financial Results on August 28, 2013 7:00 a.m. Aug. 20, 2013 - GlobeNewswire
BlackBerry plunges as it slashes jobs, forecasts 3:58 p.m. Sept. 20, 2013 - Saumya Vaishampayan
Prosensa notably higher on the day 2:26 p.m. Jan. 6, 2014 - Seeking Alpha
This FDA Letter About Sarepta and Accelerated Approval for Eteplirsen Will Blow Your Mind 12:37 p.m. Jan. 6, 2014 - TheStreet.com
The 4 Worst IPOs of 2013 12:00 a.m. Dec. 12, 2013 - InvestorPlace.com
Prosensa Holding NV's CEO Discusses Q3 2013 Results - Earnings Call Transcript 5:14 p.m. Nov. 18, 2013 - Seeking Alpha
Sarepta Therapeutics: No Longer A Momentum Play, But Long-Term Value Remains 3:30 a.m. Nov. 14, 2013 - Seeking Alpha
Glaxo's Heart Candidate Disappoints - Analyst Blog 5:20 p.m. Nov. 13, 2013 - Zacks.com
FDA Wants More Testing of Muscular-Dystrophy Drug 4:23 p.m. Nov. 12, 2013 - WSJ.com
Health-Care Stocks: Where to Find Value 6:08 a.m. Nov. 12, 2013 - Barrons.com
Sarepta Therapeutics: Underappreciated Clinical And Regulatory Risk Following Analysis Of Prosensa Failure 10:12 a.m. Oct. 30, 2013 - Seeking Alpha
Sarepta On The Move 2:44 p.m. Oct. 21, 2013 - Seeking Alpha
Insiders Are Buying Fate Therapeutics 10:20 a.m. Oct. 9, 2013 - GuruFocus.com
Sarepta Shares Continue to Inch Up - Analyst Blog 3:45 p.m. Sept. 30, 2013 - Zacks.com
Sarepta Takes The Lead In Muscular Dystrophy Race 3:25 p.m. Sept. 30, 2013 - Investors Business Daily
Is It Time To Go Long Sarepta Therapeutics? 1:34 p.m. Sept. 26, 2013 - Seeking Alpha
UPDATE: J.P. Morgan Downgrades Prosensa Following Drisapersen DEMAND-III Study Failure 7:31 a.m. Sept. 24, 2013 - benzinga.com
Prosensa Done In by Data 5:24 a.m. Sept. 24, 2013 - Barrons.com
Sarepta Therapeutics: A Bigger Cake Outweighs A Lower Chance For A Party 2:47 p.m. Sept. 23, 2013 - Seeking Alpha
Prosensa Collapses on Drug Trial Failure - Analyst Blog 12:00 p.m. Sept. 23, 2013 - Zacks.com
UPDATE: Wedbush Downgrades Prosensa Following Bad News About Drisapersen 9:34 a.m. Sept. 23, 2013 - benzinga.com
Phase III Trial Ruins Prosensa's Drisapersen, Sarepta Rallies Strongly 8:30 a.m. Sept. 23, 2013 - Seeking Alpha
Prosensa to Present Corporate Overview at the 32nd Annual J.P. Morgan Healthcare Conference 8:00 a.m. Today - GlobeNewswire
Prosensa Comments on Drisapersen Program Update 11:07 a.m. Dec. 19, 2013 - GlobeNewswire
Prosensa Announces Extraordinary Shareholders Meeting to Appoint Dr. Georges Gemayel 9:15 a.m. Dec. 10, 2013 - GlobeNewswire
Prosensa and Partners Awarded Second European Consortium FP7 Research Grant 8:00 a.m. Nov. 25, 2013 - GlobeNewswire
Prosensa Announces Third Quarter 2013 Financial Results and Recent Corporate Developments 8:01 a.m. Nov. 18, 2013 - GlobeNewswire
Prosensa Awarded Best Biotech Pipeline 2013 at the Rare & Orphan Advocacy and Research (ROAR) Awards 8:00 a.m. Nov. 15, 2013 - GlobeNewswire
Prosensa Holding N.V. to Webcast Conference Call Discussing 3rd Quarter 2013 Financial Results on November 18, 2013 8:10 a.m. Nov. 11, 2013 - GlobeNewswire
Prosensa Enrolls 100th Patient to its Natural History Study of Duchenne Muscular Dystrophy 8:01 a.m. Nov. 7, 2013 - GlobeNewswire
Prosensa to Host Conference Call to Discuss Recent Drisapersen Data Presentations 3:31 p.m. Oct. 3, 2013 - GlobeNewswire
Law Offices of Todd M. Garber Announces Investigation of Prosensa Holding B.V. 3:02 p.m. Sept. 30, 2013 - BusinessWire
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Prosensa Holding N.V. 7:30 a.m. Sept. 30, 2013 - PR Newswire
The Rosen Law Firm Announces Investigation of Shareholder Securities Claims Against Prosensa Holding NV - RNA 10:02 p.m. Sept. 27, 2013 - BusinessWire
Glancy Binkow & Goldberg LLP Encourages Investors of Prosensa Holding B.V. With Losses of $100,000 or More to Contact the Firm 8:32 p.m. Sept. 24, 2013 - BusinessWire
Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of Prosensa Holding B.V. 3:16 p.m. Sept. 24, 2013 - BusinessWire
Prosensa to Present at Upcoming Investor Conferences 12:32 p.m. Sept. 24, 2013 - GlobeNewswire
Five Star Equities Issues New Research Reports on CYCC, RNA, RVP and SRPT 7:41 a.m. Sept. 23, 2013 - ACCESSWIRE
GSK and Prosensa Announce Primary Endpoint Not Met in Phase III Study of Drisapersen in Patients With Duchenne Muscular Dystrophy 6:00 a.m. Sept. 20, 2013 - GlobeNewswire
Prosensa Initiates First Patient Dosing in Phase I/II trial of PRO053 7:30 a.m. Sept. 6, 2013 - GlobeNewswire
Prosensa Announces Second Quarter 2013 Financial Results and Recent Corporate Developments 6:00 a.m. Aug. 28, 2013 - GlobeNewswire
Prosensa Holding N.V. to Webcast Conference Call Discussing Second Quarter 2013 Financial Results on August 28, 2013 7:00 a.m. Aug. 20, 2013 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼